ADMA
ADMA Biologics, Inc.
8.61
2 x 6.26
3 x 8.82
bid
ask
+
0.24
2.87%
3 @ 08:48 AM
8.71 +0.10 (1.14%)
Ytd-52.80%
1y-51.85%
8.52
day range
8.76
7.21
52 week range
20.46
Open8.56Prev Close8.37Low8.52High8.76Mkt Cap2.00B
Vol3.04MAvg Vol5.24MEPS0.68P/E12.66Forward P/E8.63
Beta0.73Short Ratio6.37Inst. Own93.95%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-0550-d Avg8.87200-d Avg14.011yr Est17.60

ADMA News

ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm
prnewswire.com
ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit Filed by The R

NEW YORK, July 2, 2026 /PRNewswire/ --  Why: Rosen Law Firm, a global investor rights law firm, remi

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages ADMA Biologics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – ADMA
globenewswire.com
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages ADMA Biologics, Inc. Investors to Secure Counsel Be

NEW YORK, July 01, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,

ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
newsfilecorp.com
ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Conta

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - July 1, 2026) - Kahn Swick & Foti,

ADMA Biologics, Inc. (ADMA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
gurufocus.com
ADMA Biologics, Inc. (ADMA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud La

ADMA Biologics, Inc. (ADMA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud La

ADMA Biologics, Inc. (ADMA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
prnewswire.com
ADMA Biologics, Inc. (ADMA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud La

LOS ANGELES, July 1, 2026 /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP announces that investors

ADMA Biologics, Inc. Class Action Lawsuit Seeks Recovery for Investors; August 10, 2026, Deadline - Contact Kessler Topaz Meltzer & Check, LLP
globenewswire.com
ADMA Biologics, Inc. Class Action Lawsuit Seeks Recovery for Investors; August 10, 2026, Deadline -

Did you buy ADMA securities between August 9, 2024 and March 25, 2026 ? Affected ADMA Investor Summa

Bronstein, Gewirtz & Grossman LLC Urges ADMA Biologics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
newsfilecorp.com
Bronstein, Gewirtz & Grossman LLC Urges ADMA Biologics, Inc. Investors to Act: Class Action Filed Al

New York, New York--(Newsfile Corp. - July 1, 2026) - Bronstein, Gewirtz & Grossman, LLC, a national

ADMA DEADLINE: Levi & Korsinsky Reminds ADMA BIOLOGICS, INC. Investors of Upcoming Securities Class Action Deadline
prnewswire.com
ADMA DEADLINE: Levi & Korsinsky Reminds ADMA BIOLOGICS, INC. Investors of Upcoming Securities Class

ADMA Biologics allegedly certified internal controls as effective while concealing channel stuffing

ADMA BIOLOGICS, INC. INVESTORS WITH LOSSES HAVE UNTIL AUGUST 10, 2026 TO JOIN SECURITIES CLASS ACTION – Bernstein Liebhard LLP Announces Deadline
globenewswire.com
ADMA BIOLOGICS, INC. INVESTORS WITH LOSSES HAVE UNTIL AUGUST 10, 2026 TO JOIN SECURITIES CLASS ACTIO

NEW YORK, July 01, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor

INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that ADMA Biologics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
globenewswire.com
INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that ADMA Biologics, Inc. Investors with

SAN DIEGO, July 01, 2026 (GLOBE NEWSWIRE) -- The law firm of  Robbins Geller Rudman & Dowd LLP annou

ADMA Lawsuit Notification: ADMA Biologics Investors Bring Securities Class Action Following Channel Stuffing Allegations – Contact BFA Law by August 10 Deadline
globenewswire.com
ADMA Lawsuit Notification: ADMA Biologics Investors Bring Securities Class Action Following Channel

NEW YORK, July 01, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm  Bleichmar Fonti & Auld LLP

ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
globenewswire.com
ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Conta

NEW YORK and NEW ORLEANS, June 30, 2026 (GLOBE NEWSWIRE) -- Kahn Swick and Foti, LLC ("KSF") and KSF

ROSEN, LEADING TRIAL LAWYERS, Encourages ADMA Biologics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ADMA
newsfilecorp.com
ROSEN, LEADING TRIAL LAWYERS, Encourages ADMA Biologics, Inc. Investors to Secure Counsel Before Imp

New York, New York--(Newsfile Corp. - June 30, 2026) - WHY: Rosen Law Firm, a global investor rights

ADMA Biologics, Inc. (NASDAQ: ADMA) Investors Have Opportunity to Lead Securities Fraud Class Action Lawsuit
prnewswire.com
ADMA Biologics, Inc. (NASDAQ: ADMA) Investors Have Opportunity to Lead Securities Fraud Class Action

Did you buy ADMA securities between August 9, 2024 and March 25, 2026? Affected ADMA Investor Summar

ADMA INVESTOR ALERT: Faruqi & Faruqi, LLP Reminds ADMA Biologics Investors of Securities Class Action Lawsuit Deadline on August 10, 2026
newsfilecorp.com
ADMA INVESTOR ALERT: Faruqi & Faruqi, LLP Reminds ADMA Biologics Investors of Securities Class Actio

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suff

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ADMA Biologics, Inc. of Class Action Lawsuit and Upcoming Deadlines – ADMA
globenewswire.com
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ADMA Biologi

NEW YORK, June 30, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has

ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
newsfilecorp.com
ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Conta

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - June 30, 2026) - Kahn Swick & Foti,

ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
globenewswire.com
ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit with the Schal

LOS ANGELES, June 30, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights l

ADMA Biologics (NASDAQ: ADMA) Investigated for Potential Federal Securities Laws Violations – Lowey Dannenberg, P.C.
globenewswire.com
ADMA Biologics (NASDAQ: ADMA) Investigated for Potential Federal Securities Laws Violations – Lowey

NEW YORK, June 30, 2026 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C. , a top complex litigation law fir

$ADMA Notification: ADMA Biologics Accused of Misrepresentations about its Revenue Sources in Securities Fraud Class Action
prnewswire.com
$ADMA Notification: ADMA Biologics Accused of Misrepresentations about its Revenue Sources in Securi

A securities fraud class action lawsuit has been filed on behalf of ADMA Biologics investors after i

Adma Biologics (ADMA) Stock Falls Amid Market Uptick: What Investors Need to Know
zacks.com
Adma Biologics (ADMA) Stock Falls Amid Market Uptick: What Investors Need to Know

Adma Biologics (ADMA) closed at $8.37 in the latest trading session, marking a -4.34% move from the

ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
newsfilecorp.com
ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Conta

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - June 29, 2026) - Kahn Swick & Foti,

ADMA BIOLOGICS, INC. INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates ADMA Biologics, Inc.'s Directors and Officers for Breach of Fiduciary Duties – ADMA
businesswire.com
ADMA BIOLOGICS, INC. INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates ADMA Biologics, I

NEW YORK--(BUSINESS WIRE)---- $ADMA #ADMA--Scott+Scott Attorneys at Law LLP has launched an urgent i

ROSEN, SKILLED INVESTOR COUNSEL, Encourages ADMA Biologics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ADMA
newsfilecorp.com
ROSEN, SKILLED INVESTOR COUNSEL, Encourages ADMA Biologics, Inc. Investors to Secure Counsel Before

New York, New York--(Newsfile Corp. - June 29, 2026) - WHY: Rosen Law Firm, a global investor rights

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of August 10, 2026 in ADMA BIOLOGICS, INC. Lawsuit - ADMA
globenewswire.com
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of August 10, 2026 in ADMA BIOLOG

Jerrold V. Grossman, ADMA Biologics co-founder and Vice Chairman, signed annual reports that alleged

Bronstein, Gewirtz & Grossman LLC Urges ADMA Biologics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
Bronstein, Gewirtz & Grossman LLC Urges ADMA Biologics, Inc. Investors to Act: Class Action Filed Al

New class action for ADMA Biologics, Inc. urges investors to seek recovery for alleged securities fr

ADMA INVESTOR NOTICE: ADMA Biologics, Inc. (ADMA) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
prnewswire.com
ADMA INVESTOR NOTICE: ADMA Biologics, Inc. (ADMA) Investors with Substantial Losses Have Opportunity

SAN DIEGO, June 29, 2026 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces

Investor Announcement: ADMA Biologics Investors are Notified to Contact BFA Law about the Pending Securities Fraud Class Action to Recover Stock Losses
globenewswire.com
Investor Announcement: ADMA Biologics Investors are Notified to Contact BFA Law about the Pending Se

Investor Announcement: ADMA Biologics Investors are Notified to Contact BFA Law about the Pending Se

Will SpaceX Stock Double Anytime Soon? No -- but These 3 Stocks Could
fool.com
Will SpaceX Stock Double Anytime Soon? No -- but These 3 Stocks Could

Unlike SpaceX, ADMA Biologics is already profitable and has a clear path to doubling over the near t

Bronstein, Gewirtz & Grossman LLC Urges ADMA Biologics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
newsfilecorp.com
Bronstein, Gewirtz & Grossman LLC Urges ADMA Biologics, Inc. Investors to Act: Class Action Filed Al

New York, New York--(Newsfile Corp. - June 28, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationa

ROSEN, THE FIRST FILING FIRM, Encourages ADMA Biologics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – ADMA
globenewswire.com
ROSEN, THE FIRST FILING FIRM, Encourages ADMA Biologics, Inc. Investors to Secure Counsel Before Imp

NEW YORK, June 28, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,

ADMA INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds ADMA Biologics Investors of Securities Class Action Lawsuit Deadline on August 10, 2026
newsfilecorp.com
ADMA INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds ADMA Biologics Investors of Securit

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suff

Kessler Topaz Meltzer & Check, LLP - ADMA Biologics, Inc. Investors Have Opportunity to Lead Securities Fraud Class Action Lawsuit
globenewswire.com
Kessler Topaz Meltzer & Check, LLP - ADMA Biologics, Inc. Investors Have Opportunity to Lead Securit

Did you buy ADMA securities between August 9, 2024 and March 25, 2026? Did you buy ADMA securities b

ROSEN, A RANKED AND LEADING LAW FIRM, Encourages ADMA Biologics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ADMA
newsfilecorp.com
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages ADMA Biologics, Inc. Investors to Secure Counsel Be

New York, New York--(Newsfile Corp. - June 27, 2026) - WHY: Rosen Law Firm, a global investor rights

ADMA Biologics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against ADMA Biologics, Inc. - ADMA
gurufocus.com
ADMA Biologics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of

ADMA Biologics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of

ADMA Biologics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against ADMA Biologics, Inc. - ADMA
prnewswire.com
ADMA Biologics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of

NEW ORLEANS, June 26, 2026 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, remi

ADMA SHAREHOLDER ALERT: Securities Fraud Lawsuit Filed on Behalf of ADMA Biologics, Inc. Investors - Contact Kirby McInerney LLP by August 10, 2026
globenewswire.com
ADMA SHAREHOLDER ALERT: Securities Fraud Lawsuit Filed on Behalf of ADMA Biologics, Inc. Investors -

NEW YORK, June 26, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds investors who purchased ADMA

ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm
prnewswire.com
ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit Filed by The R

NEW YORK, June 26, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, remi

Deadline Alert: ADMA Biologics, Inc. (ADMA) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
globenewswire.com
Deadline Alert: ADMA Biologics, Inc. (ADMA) Shareholders Who Lost Money Urged To Contact Glancy Pron

LOS ANGELES, June 26, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors o

ADMA Shareholder Alert: ADMA Biologics, Inc. Securities Class Action Lawsuit - Investors Should Contact The Gross Law Firm
globenewswire.com
ADMA Shareholder Alert: ADMA Biologics, Inc. Securities Class Action Lawsuit - Investors Should Cont

NEW YORK, June 26, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareh

ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
globenewswire.com
ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit with the Schal

LOS ANGELES, June 26, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights l

$ADMA Fraud Alert: ADMA Biologics Investors Sue for Recovery in Securities Fraud Class Action after 29% Stock Drop – Investors Notified to Contact BFA Law
globenewswire.com
$ADMA Fraud Alert: ADMA Biologics Investors Sue for Recovery in Securities Fraud Class Action after

A securities fraud class action lawsuit has been filed on behalf of ADMA Biologics investors after i

ROSEN, THE FIRST FILING FIRM, Encourages ADMA Biologics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – ADMA
globenewswire.com
ROSEN, THE FIRST FILING FIRM, Encourages ADMA Biologics, Inc. Investors to Secure Counsel Before Imp

NEW YORK, June 25, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,

Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against ADMA Biologics, Inc. and Encourages Investors to Contact the Firm
globenewswire.com
Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against ADMA Biolog

Bragar Eagel & Squire, P.C.  Litigation Partners  Brandon Walker  and Melissa Fortunato Encourage In

INVESTOR DEADLINE: ADMA Biologics, Inc. (ADMA) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
newsfilecorp.com
INVESTOR DEADLINE: ADMA Biologics, Inc. (ADMA) Investors with Substantial Losses Have Opportunity to

San Diego, California--(Newsfile Corp. - June 25, 2026) - Robbins Geller Rudman & Dowd LLP announces

ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
newsfilecorp.com
ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Conta

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - June 25, 2026) - Kahn Swick & Foti,

CLASS ACTION NOTICE: Berger Montague Advises ADMA Biologics, Inc. (ADMA) Investors to Inquire About a Securities Fraud Class Action
feeds.newsfilecorp.com
CLASS ACTION NOTICE: Berger Montague Advises ADMA Biologics, Inc. (ADMA) Investors to Inquire About

Philadelphia, Pennsylvania--(Newsfile Corp. - June 25, 2026) - National plaintiffs' law firm Berger

ADMA Biologics, Inc. (ADMA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
prnewswire.com
ADMA Biologics, Inc. (ADMA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud La

LOS ANGELES, June 25, 2026 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors

Bronstein, Gewirtz & Grossman LLC Urges ADMA Biologics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
newsfilecorp.com
Bronstein, Gewirtz & Grossman LLC Urges ADMA Biologics, Inc. Investors to Act: Class Action Filed Al

New York, New York--(Newsfile Corp. - June 25, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationa

ADMA Biologics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against ADMA Biologics, Inc. - ADMA
globenewswire.com
ADMA Biologics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of

NEW ORLEANS, June 25, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service,